Warren R W, Griffith R C, Davie J M
Adv Exp Med Biol. 1978;98:357-69. doi: 10.1007/978-1-4615-8858-0_19.
Carrier-primed T lymphocytes can suppress high avidity IgG anti-hapten antibody secretion within 90 min. in vitro if the suppressor and target cells are primed with the same carrier determinants. Suppression seems to be directed to the antibody secreting cell since the effect is rapid and does not depend on macrophages or T cells in the target cell population. Suppression can be blocked by inclusion of soluble carrier in the cell mixture or by treatment of the target cells with anti-carrier antibody or pronase. Moreover, suppression can be augmented by PFC exposure to the soluble hapten-carrier conjugate. Finally, carrier specificity may be altered by preincubation of the target population with a hapten-heterologous carrier before addition of suppressor cells specific for the heterologous carrier. Thus, it is likely that high avidity suppression depends upon immunogen bound to the surfaces of antibody secreting cells which serves as a target for suppressor cells or molecules.
如果抑制细胞和靶细胞用相同的载体决定簇进行致敏,那么载体致敏的T淋巴细胞在体外90分钟内就能抑制高亲和力IgG抗半抗原抗体的分泌。抑制作用似乎直接针对抗体分泌细胞,因为这种效应迅速,且不依赖于靶细胞群体中的巨噬细胞或T细胞。在细胞混合物中加入可溶性载体,或用抗载体抗体或链霉蛋白酶处理靶细胞,均可阻断抑制作用。此外,通过将空斑形成细胞(PFC)暴露于可溶性半抗原-载体偶联物,可增强抑制作用。最后,在加入对异源载体具有特异性的抑制细胞之前,先用半抗原-异源载体对靶细胞群体进行预孵育,可能会改变载体特异性。因此,高亲和力抑制作用很可能依赖于与抗体分泌细胞表面结合的免疫原,而这种免疫原可作为抑制细胞或分子的靶标。